GlassScriptPhysician profile
Alycia Davidson
NPI 1336765387
$4,900.47
in general payments reported to CMS, 2019-2025
12 companies · $2,302 in 2025
The $2,302 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.72 · 2023: $203 · 2024: $2,357 · 2025: $2,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,880 · Food and Beverage: $1,923 · Education: $58.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,880.18 |
| Food and Beverage | $1,923.07 |
| Education | $58.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,249.91 | 2023-2025 | Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $2,243.78 | 2024-2025 | Watchman Flx, General - Therapies |
| E.R. Squibb & Sons, L.L.C. | $127.40 | 2023-2024 | Camzyos |
| Janssen Pharmaceuticals, INC | $106.43 | 2023-2024 | Xarelto |
| Novo Nordisk INC | $38.72 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.06 | 2023 | |
| Daiichi Sankyo INC. | $28.56 | 2024 | Injectafer |
| Pfizer INC. | $17.40 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $14.74 | 2024 | Evkeeza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.57 | 2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.35 | 2024-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $13.55 | 2024 | Opsumit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alycia Davidson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.